Back to discover
Disease

Adrenal Cortex Neoplasms

Active therapeutic pipelineEmerging research
MeSHAdrenal Cortex Neoplasms
1
Publications
3
Clinical trials
2
Associated genes
2
Related proteins
2020
Latest publication
Current focus
Therapeutic developmentMetabolic & lifestyle factorsDisease mechanisms & pathology
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Research2020-08-27Annals of oncology : official journal of the European Society for Medical Oncology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2027.
Upcoming Milestones
Clinical Milestones1View
Results expected 1
Activity timeline1

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
3
All trials
1
Active
0
Late-stage
2
Completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology · 2020 · 276 cites
Recent publications

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology · 2020 · 276 cites
Major themes4
  • Adrenal Cortex Neoplasms1
  • Adrenal Gland Neoplasms1
  • Adrenocortical Carcinoma1
  • Pheochromocytoma1
Leading journals1
  • Annals of oncology : official journal of the European Society for Medical Oncology1
Leading researchers8
  • Assie G1
  • Baudin E1
  • Berruti A1
  • de Krijger R1
  • de la Fouchardiere C1
  • Eisenhofer G1
  • Fassnacht M1
  • Haak HR1
Affiliations (unnormalised)6
  • Centre Léon Bérard1
  • Department of Clinical and Biological Sciences1
  • Department of Medicine III and Institute of Clinical Chemistry and Laboratory Medicine1
  • Maastricht University Medical Centre1
  • Reference Centre for Rare Adrenal Diseases1
  • San Luigi Hospital - Orbassano1

Associated genes

2 matches

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

CYP11B10.37CYP11A10.37

Disease biology

2 matches

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

Cytochrome P450 11B1, mitochondrialvia CYP11B10.37Cholesterol side-chain cleavage enzyme, mitochondrialvia CYP11A10.37

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Tumors or cancers of the ADRENAL CORTEX.

Identifiers
MeSHAdrenal Cortex Neoplasms
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.